With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Multivalent Nanomedicine to Treat High-Risk Pediatric Solid Tumors||Children's Hospital of Philadelphia / Garrett Brodeur, MD||Reach Grants||2019||Pennsylvania|
|Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion||Research Institute at Nationwide Children's Hospital / Dean Lee, MD/PhD||Reach Grants||2019||Ohio|
|Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas||New York University School of Medicine / Danny Reinberg, PhD||Reach Grants||2019||New York|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers||University of Texas Southwestern Medical Center / James Amatruda, MD, PhD||Reach Grants||2013||Texas|
|Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma||Children's Hospital of Philadelphia / John Maris, MD||Reach Grants||2016||Pennsylvania|
|Targeting PLK1 as a Common Mechanism in Ph-like ALL||University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD||Reach Grants||2016||Texas|
|Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor||Baylor College of Medicine / William Decker, PhD||Reach Grants||2013||Texas|
|Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma||The Johns Hopkins University School of Medicine / David Loeb, MD, PhD||Reach Grants||2013||Maryland|